AIMEDBIO

IR

Disclosure

69 posts
NO. Title Date Author
59 [Corrected description]Material Management Information related to Judgment of Investment(Application for IND Approval) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청) 2026-07-15 에임드바이오
58 Announcement of convocation of general meeting of shareholders 2026-07-01 에임드바이오
57 Notice on Investor Relations 2026-06-30 에임드바이오
56 Material Management Information related to Judgment of Investment (ODS025 기술이전계약 관련 마일스톤 기술료 수령) 2026-06-26 에임드바이오
55 Material Management Information related to Judgment of Investment(IND Approval Determination) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인) 2026-06-26 에임드바이오
54 [Corrected description]Material Management Information related to Judgment of Investment(Application for IND Approval) (BI 4060107 (ODS025)의 제 1상 임상시험계획 승인 신청) 2026-06-16 에임드바이오
53 Closure of Register of Shareholders or Designation of Record Date 2026-06-05 에임드바이오
52 Resolutions for Convocation of General Meeting of Shareholders (임시주주총회) 2026-06-05 에임드바이오
51 Material Management Information related to Judgment of Investment(Application for IND Approval) 2026-05-27 에임드바이오
50 [Corrected description]Quarterly Report (2026.03) 2026-05-15 에임드바이오
1 2 3 4 5